Tamoxifen Pharmacogenetics and Metabolism: The Same Is Not the Same

被引：16

作者：

Brauch, Hiltrud ^{[1
,2
,3
,4
]}

Schroth, Werner ^{[1
,2
]}

Muerdter, Thomas ^{[1
,2
]}

Schwab, Matthias ^{[1
,2
,3
,4
]}

机构：

[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany

[2] Univ Tubingen, Tubingen, Germany

[3] German Canc Consortium DKTK, Heidelberg, Germany

[4] German Canc Res Ctr, Heidelberg, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 22期

关键词：

BREAST-CANCER; CYP2D6; GENOTYPE; POSTMENOPAUSAL WOMEN; POLYMORPHISMS; OUTCOMES;

D O I：

10.1200/JCO.19.00507

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1981 / +

页数：3

共 11 条

[1] Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer [J].

Brauch, Hiltrud ;

Schwab, Matthias .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) :695-703

[2] Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes [J].

Goetz, MP ;

Rae, JM ;

Suman, VJ ;

Safgren, SL ;

Ames, MM ;

Visscher, DW ;

Reynolds, C ;

Couch, FJ ;

Lingle, WL ;

Flockhart, DA ;

Desta, Z ;

Perez, EA ;

Ingle, JN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9312-9318

[3]

Gonzalez-Santiago S, 2007, J CLIN ONCOL, V25

[4] Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes [J].

Madlensky, L. ;

Natarajan, L. ;

Tchu, S. ;

Pu, M. ;

Mortimer, J. ;

Flatt, S. W. ;

Nikoloff, D. M. ;

Hillman, G. ;

Fontecha, M. R. ;

Lawrence, H. J. ;

Parker, B. A. ;

Wu, A. H. B. ;

Pierce, J. P. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) :718-725

[5] Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma [J].

Muerdter, T. E. ;

Schroth, W. ;

Bacchus-Gerybadze, L. ;

Winter, S. ;

Heinkele, G. ;

Simon, W. ;

Fasching, P. A. ;

Fehm, T. ;

Eichelbaum, M. ;

Schwab, M. ;

Brauch, H. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) :708-717

[6] CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations [J].

Province, M. A. ;

Goetz, M. P. ;

Brauch, H. ;

Flockhare, D. A. ;

Hebert, J. M. ;

Whaley, R. ;

Suman, V. J. ;

Schroth, W. ;

Winter, S. ;

Zembutsu, H. ;

Mushiroda, T. ;

Newman, W. G. ;

Lee, M-T M. ;

Ambrosone, C. B. ;

Beckmann, M. W. ;

Choi, J-Y ;

Dieudonne, A-S ;

Fasching, P. A. ;

Ferraldeschi, R. ;

Gong, L. ;

Haschke-Becher, E. ;

Howel, A. ;

Jordan, L. B. ;

Hamann, U. ;

Kiyotani, K. ;

Krippl, P. ;

Lambrechts, D. ;

Latif, A. ;

Langsenlehner, U. ;

Lorizio, W. ;

Neven, P. ;

Nguyen, A. T. ;

Park, B-W ;

Purdie, C. A. ;

Quinlan, P. ;

Renner, W. ;

Schmidt, M. ;

Schwab, M. ;

Shin, J-G ;

Stingl, J. C. ;

Wegman, P. ;

Wingren, S. ;

Wu, A. H. B. ;

Ziv, E. ;

Zirpoli, G. ;

Thompson, A. M. ;

Jordan, V. C. ;

Nakamura, Y. ;

Altman, R. B. ;

Ames, M. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) :216-227

[7] CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [J].

Rae, James M. ;

Drury, Suzy ;

Hayes, Daniel F. ;

Stearns, Vered ;

Thibert, Jacklyn N. ;

Haynes, Ben P. ;

Salter, Janine ;

Sestak, Ivana ;

Cuzick, Jack ;

Dowsett, Mitch .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (06) :452-460

[8] CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial [J].

Regan, Meredith M. ;

Leyland-Jones, Brian ;

Bouzyk, Mark ;

Pagani, Olivia ;

Tang, Weining ;

Kammler, Roswitha ;

Dell'Orto, Patrizia ;

Biasi, Maria Olivia ;

Thuerlimann, Beat ;

Lyng, Maria B. ;

Ditzel, Henrik J. ;

Neven, Patrick ;

Debled, Marc ;

Maibach, Rudolf ;

Price, Karen N. ;

Gelber, Richard D. ;

Coates, Alan S. ;

Goldhirsch, Aron ;

Rae, James M. ;

Viale, Giuseppe .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (06) :441-451

[9] Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study [J].

Sanchez-Spitman, Anabel ;

Dezentje, Vincent ;

Swen, Jesse ;

Moes, Dirk Jan A. R. ;

Bohringer, Stefan ;

Batman, Erdogan ;

van Druten, Edith ;

Smorenburg, Carolien ;

van Bochove, Aart ;

Zeillemaker, Anneke ;

Jongen, Lynn ;

Los, Maartje ;

Neven, Patrick ;

Gelderblom, Hans ;

Guchelaar, Henk-Jan .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08) :636-+

[10] Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [J].

Schroth, Werner ;

Goetz, Matthew P. ;

Hamann, Ute ;

Fasching, Peter A. ;

Schmidt, Marcus ;

Winter, Stefan ;

Fritz, Peter ;

Simon, Wolfgang ;

Suman, Vera J. ;

Ames, Matthew M. ;

Safgren, Stephanie L. ;

Kuffel, Mary J. ;

Ulmer, Hans Ulrich ;

Bolaender, Julia ;

Strick, Reiner ;

Beckmann, Matthias W. ;

Koelbl, Heinz ;

Weinshilboum, Richard M. ;

Ingle, James N. ;

Eichelbaum, Michel ;

Schwab, Matthias ;

Brauch, Hiltrud .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (13) :1429-1436

← 1 2 →